Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies. (2021)
Attributed to:
Combination immunotherapy for solid tumours with oncolytic virus & cognate CAR T-cells
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00005-021-00640-7
PubMed Identifier: 34897554
Publication URI: http://europepmc.org/abstract/MED/34897554
Type: Journal Article/Review
Volume: 70
Parent Publication: Archivum immunologiae et therapiae experimentalis
Issue: 1
ISSN: 0004-069X